{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:16:12Z","timestamp":1795140972530,"version":"4.10.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["Start-up grant"],"award-info":[{"award-number":["Start-up grant"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["T2EP30221-0013"],"award-info":[{"award-number":["T2EP30221-0013"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The limited therapeutic options for metabolic dysfunction-associated steatotic liver disease (MASLD) underscore the need for deeper mechanistic insight and new treatment strategies. Here, we identify the orphan G protein-coupled receptor GPR146 as a regulator of hepatic steatosis through adipose\u2013liver crosstalk. Human genetic analyses link the GPR146 locus to circulating markers of liver injury and inflammation. In mice, both constitutive and acute GPR146 depletion protect against diet-induced obesity and hepatic steatosis. Notably, adipose-specific, but not liver-specific, GPR146 deletion reduces hepatic lipid accumulation by limiting free fatty acid (FFA) influx. Mechanistically, GPR146 promotes adipogenesis in preadipocytes via G\u03b1q-PKC-AKT signaling, increasing lipid storage capacity, and enhances lipolysis in mature adipocytes through ERK activation, elevating circulating FFA. Together, these coordinated actions increase FFA delivery to the liver, promoting triglyceride accumulation. Our findings establish GPR146 as a pleiotropic regulator of adipose tissue biology and a potential therapeutic target for MASLD.<\/jats:p>","DOI":"10.1038\/s41467-026-70136-5","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:44:48Z","timestamp":1772559888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["GPR146 in adipose tissue drives adipose-liver crosstalk and promotes hepatic steatosis in mice"],"prefix":"10.1038","volume":"17","author":[{"given":"Yu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Tun","family":"Thi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanna","family":"Chhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Ting","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9687-0953","authenticated-orcid":false,"given":"Amy","family":"Deik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6795-8430","authenticated-orcid":false,"given":"Martin","family":"Wabitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-9245","authenticated-orcid":false,"given":"Clary B.","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1787-6925","authenticated-orcid":false,"given":"Alexander S.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2455-2526","authenticated-orcid":false,"given":"Radoslaw M.","family":"Sobota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad A.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0559-0252","authenticated-orcid":false,"given":"Haojie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"70136_CR1","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl, A. M. & Day, C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N. Engl. J. Med. 377, 2063\u20132072 (2017).","journal-title":"N. Engl. J. Med."},{"key":"70136_CR2","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"385","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal, A. J. et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N. Engl. J. Med. 385, 1559\u20131569 (2021).","journal-title":"N. Engl. J. Med."},{"key":"70136_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo, P. et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149, 389\u2013397 e310 (2015).","journal-title":"Gastroenterology"},{"key":"70136_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/13543784.2020.1703949","volume":"29","author":"K Qureshi","year":"2020","unstructured":"Qureshi, K. & Neuschwander-Tetri, B. A. The molecular basis for current targets of NASH therapies. Expert Opin. Investig. Drugs 29, 151\u2013161 (2020).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"70136_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/liv.14354","volume":"40","author":"AC Cardoso","year":"2020","unstructured":"Cardoso, A. C., de Figueiredo-Mendes, C., C, A. V.-N. & Sanyal, A. J. New drugs for non-alcoholic steatohepatitis. Liver Int. 40, 96\u2013101 (2020).","journal-title":"Liver Int"},{"key":"70136_CR6","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","volume":"392","author":"AJ Sanyal","year":"2025","unstructured":"Sanyal, A. J. et al. Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis. N. Engl. J. Med. 392, 2089\u20132099 (2025).","journal-title":"N. Engl. J. Med."},{"key":"70136_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","volume":"27","author":"VT Samuel","year":"2018","unstructured":"Samuel, V. T. & Shulman, G. I. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab. 27, 22\u201341 (2018).","journal-title":"Cell Metab."},{"key":"70136_CR8","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","volume":"23","author":"BJ Perumpail","year":"2017","unstructured":"Perumpail, B. J. et al. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J. Gastroenterol. 23, 8263\u20138276 (2017).","journal-title":"World J. Gastroenterol."},{"key":"70136_CR9","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jhep.2023.01.024","volume":"78","author":"E Lee","year":"2023","unstructured":"Lee, E., Korf, H. & Vidal-Puig, A. An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease. J. Hepatol. 78, 1048\u20131062 (2023).","journal-title":"J. Hepatol."},{"key":"70136_CR10","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1111\/febs.15800","volume":"288","author":"LF Barella","year":"2021","unstructured":"Barella, L. F., Jain, S., Kimura, T. & Pydi, S. P. Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes. FEBS J. 288, 2622\u20132644 (2021).","journal-title":"FEBS J."},{"key":"70136_CR11","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1172\/JCI83626","volume":"127","author":"I Ruiz de Azua","year":"2017","unstructured":"Ruiz de Azua, I. et al. Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages. J. Clin. Invest. 127, 4148\u20134162 (2017).","journal-title":"J. Clin. Invest"},{"key":"70136_CR12","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2019.10.034","volume":"179","author":"H Yu","year":"2019","unstructured":"Yu, H. et al. GPR146 deficiency protects against hypercholesterolemia and atherosclerosis. Cell 179, 1276\u20131288 e1214 (2019).","journal-title":"Cell"},{"key":"70136_CR13","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/s41588-018-0222-9","volume":"50","author":"D Klarin","year":"2018","unstructured":"Klarin, D. et al. Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. Nat. Genet 50, 1514\u20131523 (2018).","journal-title":"Nat. Genet"},{"key":"70136_CR14","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/ng.3977","volume":"49","author":"DJ Liu","year":"2017","unstructured":"Liu, D. J. et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat. Genet 49, 1758\u20131766 (2017).","journal-title":"Nat. Genet"},{"key":"70136_CR15","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer, C. J. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet 45, 1274\u20131283 (2013).","journal-title":"Nat. Genet"},{"key":"70136_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41422-020-0303-z","volume":"30","author":"F Han","year":"2020","unstructured":"Han, F. et al. Hypercholesterolemia risk-associated GPR146 is an orphan G-protein coupled receptor that regulates blood cholesterol levels in humans and mice. Cell Res. 30, 363\u2013365 (2020).","journal-title":"Cell Res"},{"key":"70136_CR17","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/ATVBAHA.122.317514","volume":"42","author":"A Rimbert","year":"2022","unstructured":"Rimbert, A. et al. Variants in the GPR146 gene are associated with a favorable cardiometabolic risk profile. Arterioscler Thromb. Vasc. Biol. 42, 1262\u20131271 (2022).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"70136_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.cmet.2023.03.001","volume":"35","author":"MC Costanzo","year":"2023","unstructured":"Costanzo, M. C. et al. The type 2 diabetes knowledge portal: An open access genetic resource dedicated to type 2 diabetes and related traits. Cell Metab. 35, 695\u2013710 e696 (2023).","journal-title":"Cell Metab."},{"key":"70136_CR19","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1194\/jlr.M007096","volume":"51","author":"AE Feldstein","year":"2010","unstructured":"Feldstein, A. E. et al. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Lipid Res. 51, 3046\u20133054 (2010).","journal-title":"J. Lipid Res"},{"key":"70136_CR20","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1172\/JCI95995","volume":"127","author":"JF O\u2019Sullivan","year":"2017","unstructured":"O\u2019Sullivan, J. F. et al. Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. J. Clin. Invest. 127, 4394\u20134402 (2017).","journal-title":"J. Clin. Invest"},{"key":"70136_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.livres.2018.12.001","volume":"2","author":"YK Lee","year":"2018","unstructured":"Lee, Y. K., Park, J. E., Lee, M. & Hardwick, J. P. Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2. Liver Res. 2, 209\u2013215 (2018).","journal-title":"Liver Res."},{"key":"70136_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jnutbio.2010.04.009","volume":"22","author":"T Yamazaki","year":"2011","unstructured":"Yamazaki, T., Shiraishi, S., Kishimoto, K., Miura, S. & Ezaki, O. An increase in liver PPARgamma2 is an initial event to induce fatty liver in response to a diet high in butter: PPARgamma2 knockdown improves fatty liver induced by high-saturated fat. J. Nutr. Biochem 22, 543\u2013553 (2011).","journal-title":"J. Nutr. Biochem"},{"key":"70136_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1172\/JCI200317223","volume":"111","author":"K Matsusue","year":"2003","unstructured":"Matsusue, K. et al. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J. Clin. Invest. 111, 737\u2013747 (2003).","journal-title":"J. Clin. Invest"},{"key":"70136_CR24","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1096\/fj.10-173716","volume":"25","author":"E Moran-Salvador","year":"2011","unstructured":"Moran-Salvador, E. et al. Role for PPARgamma in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts. FASEB J. 25, 2538\u20132550 (2011).","journal-title":"FASEB J."},{"key":"70136_CR25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/brv.12140","volume":"90","author":"A Stincone","year":"2015","unstructured":"Stincone, A. et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol. Rev. Camb. Philos. Soc. 90, 927\u2013963 (2015).","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"70136_CR26","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/j.cmet.2024.10.001","volume":"36","author":"Y Liao","year":"2024","unstructured":"Liao, Y. et al. Amino acid is a major carbon source for hepatic lipogenesis. Cell Metab. 36, 2437\u20132448 e2438 (2024).","journal-title":"Cell Metab."},{"key":"70136_CR27","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cmet.2018.06.019","volume":"28","author":"AI Mina","year":"2018","unstructured":"Mina, A. I. et al. CalR: A web-based analysis tool for indirect calorimetry experiments. Cell Metab. 28, 656\u2013666 e651 (2018).","journal-title":"Cell Metab."},{"key":"70136_CR28","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s42255-025-01360-4","volume":"7","author":"AS Banks","year":"2025","unstructured":"Banks, A. S. et al. A consensus guide to preclinical indirect calorimetry experiments. Nat. Metab. 7, 1765\u20131780 (2025).","journal-title":"Nat. Metab."},{"key":"70136_CR29","doi-asserted-by":"publisher","unstructured":"Sjostedt, E. et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science 367. https:\/\/doi.org\/10.1126\/science.aay5947 (2020).","DOI":"10.1126\/science.aay5947"},{"key":"70136_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-450","volume":"13","author":"EY Kwon","year":"2012","unstructured":"Kwon, E. Y. et al. Time-course microarrays reveal early activation of the immune transcriptome and adipokine dysregulation leads to fibrosis in visceral adipose depots during diet-induced obesity. BMC Genomics 13, 450 (2012).","journal-title":"BMC Genomics"},{"key":"70136_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/ijo.2017.224","volume":"42","author":"IP Fischer","year":"2018","unstructured":"Fischer, I. P. et al. A history of obesity leaves an inflammatory fingerprint in liver and adipose tissue. Int J. Obes. (Lond.) 42, 507\u2013517 (2018).","journal-title":"Int J. Obes. (Lond.)"},{"key":"70136_CR32","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cmet.2025.01.012","volume":"37","author":"J Zhong","year":"2025","unstructured":"Zhong, J. et al. adiposetissue.org: A knowledge portal integrating clinical and experimental data from human adipose tissue. Cell Metab. 37, 566\u2013569 (2025).","journal-title":"Cell Metab."},{"key":"70136_CR33","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-025-09233-2","volume":"644","author":"AMA Miranda","year":"2025","unstructured":"Miranda, A. M. A. et al. Selective remodelling of the adipose niche in obesity and weight loss. Nature 644, 769\u2013779 (2025).","journal-title":"Nature"},{"key":"70136_CR34","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","volume":"24","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis. Cell Metab. 24, 848\u2013862 (2016).","journal-title":"Cell Metab."},{"key":"70136_CR35","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41580-018-0093-z","volume":"20","author":"AL Ghaben","year":"2019","unstructured":"Ghaben, A. L. & Scherer, P. E. Adipogenesis and metabolic health. Nat. Rev. Mol. Cell Biol. 20, 242\u2013258 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"70136_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"70136_CR37","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1093\/bioinformatics\/btx415","volume":"33","author":"DD Wiredja","year":"2017","unstructured":"Wiredja, D. D., Koyuturk, M. & Chance, M. R. The KSEA App: a web-based tool for kinase activity inference from quantitative phosphoproteomics. Bioinformatics 33, 3489\u20133491 (2017).","journal-title":"Bioinformatics"},{"key":"70136_CR38","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1210\/endo-127-2-865","volume":"127","author":"H Hauner","year":"1990","unstructured":"Hauner, H. Complete adipose differentiation of 3T3 L1 cells in a chemically defined medium: comparison to serum-containing culture conditions. Endocrinology 127, 865\u2013872 (1990).","journal-title":"Endocrinology"},{"key":"70136_CR39","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1210\/endo.140.7.6989","volume":"140","author":"JE Reusch","year":"1999","unstructured":"Reusch, J. E. & Klemm, D. J. Nutrition and fat cell differentiation. Endocrinology 140, 2935\u20132937 (1999).","journal-title":"Endocrinology"},{"key":"70136_CR40","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1146\/annurev-biochem-060614-033910","volume":"87","author":"WI Weis","year":"2018","unstructured":"Weis, W. I. & Kobilka, B. K. The molecular basis of G protein-coupled receptor activation. Annu Rev. Biochem 87, 897\u2013919 (2018).","journal-title":"Annu Rev. Biochem"},{"key":"70136_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrc2069","volume":"7","author":"RT Dorsam","year":"2007","unstructured":"Dorsam, R. T. & Gutkind, J. S. G-protein-coupled receptors and cancer. Nat. Rev. Cancer 7, 79\u201394 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"70136_CR42","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.molcel.2019.03.021","volume":"74","author":"G Wang","year":"2019","unstructured":"Wang, G. et al. Regulation of UCP1 and Mitochondrial Metabolism in Brown Adipose Tissue by Reversible Succinylation. Mol. Cell 74, 844\u2013857 e847 (2019).","journal-title":"Mol. Cell"},{"key":"70136_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature17399","volume":"532","author":"ET Chouchani","year":"2016","unstructured":"Chouchani, E. T. et al. Mitochondrial ROS regulate thermogenic energy expenditure and sulfenylation of UCP1. Nature 532, 112\u2013116 (2016).","journal-title":"Nature"},{"key":"70136_CR44","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10111","volume":"474","author":"JM Lee","year":"2011","unstructured":"Lee, J. M. et al. A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects. Nature 474, 506\u2013510 (2011).","journal-title":"Nature"},{"key":"70136_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.ijo.0801520","volume":"25","author":"M Wabitsch","year":"2001","unstructured":"Wabitsch, M. et al. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J. Obes. Relat. Metab. Disord. 25, 8\u201315 (2001).","journal-title":"Int J. Obes. Relat. Metab. Disord."},{"key":"70136_CR46","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1194\/jlr.D023788","volume":"53","author":"M Galarraga","year":"2012","unstructured":"Galarraga, M. et al. Adiposoft: Automated software for the analysis of white adipose tissue cellularity in histological sections. J. Lipid Res. 53, 2791\u20132796 (2012).","journal-title":"J. Lipid Res"},{"key":"70136_CR47","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.117.029468","volume":"137","author":"NP Paynter","year":"2018","unstructured":"Paynter, N. P. et al. Metabolic predictors of incident coronary heart disease in women. Circulation 137, 841\u2013853 (2018).","journal-title":"Circulation"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70136-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70136-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70136-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T15:02:15Z","timestamp":1775746935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70136-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70136"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70136-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"26 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.A.C. is a founder of CRISPR Therapeutics, Sana Biotechnology, and CLADE Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3389"}}